Teleflex Incorporated (NYSE: TFX) Stock Competitors & Peer Comparison
See TFX's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for TFX and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TFX | $129.02 | -0.98% | 5.7B | 14.75 | $8.75 | +1.06% |
| ISRG | $377.16 | -0.21% | 133.2B | 39.21 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.13% |
| BDX | $185.92 | +1.65% | 51.2B | 14.30 | $13.00 | +2.13% |
| RMD | $229.44 | +2.89% | 33.3B | 21.32 | $10.77 | +1.06% |
| MDLN | $32.11 | -1.47% | 27.2B | 23.53 | $1.36 | N/A |
| WST | $365.00 | +2.76% | 25.7B | 42.93 | $8.50 | +0.24% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $90.06 | +0.27% | 15.6B | 12.69 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.13% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
TFX vs ISRG Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, ISRG has a market cap of 133.2B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while ISRG trades at $377.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas ISRG's P/E ratio is 39.21. In terms of profitability, TFX's ROE is -0.32%, compared to ISRG's ROE of +0.18%. Regarding short-term risk, TFX is more volatile compared to ISRG. This indicates higher risk in terms of short-term price fluctuations for TFX.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
TFX vs BDXA Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas BDXA's P/E ratio is 45.70. In terms of profitability, TFX's ROE is -0.32%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, TFX is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for TFX.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
TFX vs BDX Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, BDX has a market cap of 51.2B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while BDX trades at $185.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas BDX's P/E ratio is 14.30. In terms of profitability, TFX's ROE is -0.32%, compared to BDX's ROE of +0.04%. Regarding short-term risk, TFX is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for TFX.Check BDX's competition here
ResMed Inc. (NYSE: RMD)
TFX vs RMD Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, RMD has a market cap of 33.3B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while RMD trades at $229.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas RMD's P/E ratio is 21.32. In terms of profitability, TFX's ROE is -0.32%, compared to RMD's ROE of +0.24%. Regarding short-term risk, TFX is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for TFX.Check RMD's competition here
Medline Inc. (NASDAQ: MDLN)
TFX vs MDLN Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, MDLN has a market cap of 27.2B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while MDLN trades at $32.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas MDLN's P/E ratio is 23.53. In terms of profitability, TFX's ROE is -0.32%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, TFX is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for TFX.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
TFX vs WST Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, WST has a market cap of 25.7B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while WST trades at $365.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas WST's P/E ratio is 42.93. In terms of profitability, TFX's ROE is -0.32%, compared to WST's ROE of +0.19%. Regarding short-term risk, TFX is less volatile compared to WST. This indicates lower risk in terms of short-term price fluctuations for TFX.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
TFX vs HOLX Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas HOLX's P/E ratio is 31.54. In terms of profitability, TFX's ROE is -0.32%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, TFX is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for TFX.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
TFX vs SOLV Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, SOLV has a market cap of 15.6B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while SOLV trades at $90.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas SOLV's P/E ratio is 12.69. In terms of profitability, TFX's ROE is -0.32%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, TFX is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for TFX.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
TFX vs BDXB Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas BDXB's P/E ratio is 7.60. In terms of profitability, TFX's ROE is -0.32%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, TFX is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for TFX.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
TFX vs BAX Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, BAX has a market cap of 12.3B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while BAX trades at $23.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas BAX's P/E ratio is 11.39. In terms of profitability, TFX's ROE is -0.32%, compared to BAX's ROE of -0.17%. Regarding short-term risk, TFX is less volatile compared to BAX. This indicates lower risk in terms of short-term price fluctuations for TFX.Check BAX's competition here
Avantor, Inc. (NYSE: AVTR)
TFX vs AVTR Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, AVTR has a market cap of 10.4B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while AVTR trades at $15.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas AVTR's P/E ratio is 18.15. In terms of profitability, TFX's ROE is -0.32%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, TFX is more volatile compared to AVTR. This indicates higher risk in terms of short-term price fluctuations for TFX.Check AVTR's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
TFX vs COO Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, COO has a market cap of 10.4B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while COO trades at $53.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas COO's P/E ratio is 11.68. In terms of profitability, TFX's ROE is -0.32%, compared to COO's ROE of +0.07%. Regarding short-term risk, TFX is less volatile compared to COO. This indicates lower risk in terms of short-term price fluctuations for TFX.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
TFX vs RGEN Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, RGEN has a market cap of 9.9B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while RGEN trades at $174.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas RGEN's P/E ratio is 97.07. In terms of profitability, TFX's ROE is -0.32%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, TFX is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for TFX.Check RGEN's competition here
AptarGroup, Inc. (NYSE: ATR)
TFX vs ATR Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, ATR has a market cap of 8B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while ATR trades at $124.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas ATR's P/E ratio is 21.79. In terms of profitability, TFX's ROE is -0.32%, compared to ATR's ROE of +0.14%. Regarding short-term risk, TFX is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for TFX.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
TFX vs BLCO Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, BLCO has a market cap of 6.2B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while BLCO trades at $17.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas BLCO's P/E ratio is 26.52. In terms of profitability, TFX's ROE is -0.32%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, TFX is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for TFX.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
TFX vs STVN Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, STVN has a market cap of 5.9B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while STVN trades at $21.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas STVN's P/E ratio is 32.57. In terms of profitability, TFX's ROE is -0.32%, compared to STVN's ROE of +0.09%. Regarding short-term risk, TFX is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for TFX.Check STVN's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
TFX vs MMSI Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, MMSI has a market cap of 5.1B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while MMSI trades at $86.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas MMSI's P/E ratio is 22.04. In terms of profitability, TFX's ROE is -0.32%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, TFX is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for TFX.Check MMSI's competition here
Envista Holdings Corp (NYSE: NVST)
TFX vs NVST Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, NVST has a market cap of 4B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while NVST trades at $24.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas NVST's P/E ratio is 16.85. In terms of profitability, TFX's ROE is -0.32%, compared to NVST's ROE of +0.04%. Regarding short-term risk, TFX is less volatile compared to NVST. This indicates lower risk in terms of short-term price fluctuations for TFX.Check NVST's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
TFX vs ICUI Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, ICUI has a market cap of 3.9B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while ICUI trades at $155.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas ICUI's P/E ratio is 19.46. In terms of profitability, TFX's ROE is -0.32%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, TFX is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for TFX.Check ICUI's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
TFX vs PLSE Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, PLSE has a market cap of 3.8B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while PLSE trades at $55.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas PLSE's P/E ratio is -46.78. In terms of profitability, TFX's ROE is -0.32%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, TFX is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for TFX.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
TFX vs ATRC Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, ATRC has a market cap of 2.9B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while ATRC trades at $56.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas ATRC's P/E ratio is 1745.96. In terms of profitability, TFX's ROE is -0.32%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, TFX is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for TFX.Check ATRC's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
TFX vs XRAY Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, XRAY has a market cap of 2B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while XRAY trades at $9.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas XRAY's P/E ratio is 6.87. In terms of profitability, TFX's ROE is -0.32%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, TFX is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for TFX.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
TFX vs LMAT Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, LMAT has a market cap of 1.8B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while LMAT trades at $80.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas LMAT's P/E ratio is 29.69. In terms of profitability, TFX's ROE is -0.32%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, TFX is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for TFX.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
TFX vs BLFS Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, BLFS has a market cap of 1.8B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while BLFS trades at $36.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas BLFS's P/E ratio is -172.18. In terms of profitability, TFX's ROE is -0.32%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, TFX is more volatile compared to BLFS. This indicates higher risk in terms of short-term price fluctuations for TFX.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
TFX vs AZTA Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, AZTA has a market cap of 1.5B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while AZTA trades at $33.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas AZTA's P/E ratio is 78.64. In terms of profitability, TFX's ROE is -0.32%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, TFX is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for TFX.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
TFX vs KMTS Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, KMTS has a market cap of 1.5B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while KMTS trades at $25.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas KMTS's P/E ratio is -9.50. In terms of profitability, TFX's ROE is -0.32%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, TFX is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for TFX.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
TFX vs STAA Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, STAA has a market cap of 1.1B. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while STAA trades at $22.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas STAA's P/E ratio is 39.38. In terms of profitability, TFX's ROE is -0.32%, compared to STAA's ROE of +0.01%. Regarding short-term risk, TFX is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for TFX.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
TFX vs ATRI Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas ATRI's P/E ratio is 64.50. In terms of profitability, TFX's ROE is -0.32%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, TFX is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for TFX.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
TFX vs ANGO Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, ANGO has a market cap of 648.1M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while ANGO trades at $15.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas ANGO's P/E ratio is -40.21. In terms of profitability, TFX's ROE is -0.32%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, TFX is less volatile compared to ANGO. This indicates lower risk in terms of short-term price fluctuations for TFX.Check ANGO's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
TFX vs SMTI Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, SMTI has a market cap of 322.8M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while SMTI trades at $35.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas SMTI's P/E ratio is -585.17. In terms of profitability, TFX's ROE is -0.32%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, TFX is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for TFX.Check SMTI's competition here
Embecta Corp. (NASDAQ: EMBC)
TFX vs EMBC Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, EMBC has a market cap of 302M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while EMBC trades at $5.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas EMBC's P/E ratio is 1.96. In terms of profitability, TFX's ROE is -0.32%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, TFX is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for TFX.Check EMBC's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
TFX vs NNNN Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, NNNN has a market cap of 241.8M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while NNNN trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas NNNN's P/E ratio is 79.62. In terms of profitability, TFX's ROE is -0.32%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, TFX is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for TFX.Check NNNN's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
TFX vs OSUR Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, OSUR has a market cap of 238.2M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while OSUR trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas OSUR's P/E ratio is -5.01. In terms of profitability, TFX's ROE is -0.32%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, TFX is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for TFX.Check OSUR's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
TFX vs UTMD Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, UTMD has a market cap of 237.6M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while UTMD trades at $74.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas UTMD's P/E ratio is 22.08. In terms of profitability, TFX's ROE is -0.32%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, TFX is less volatile compared to UTMD. This indicates lower risk in terms of short-term price fluctuations for TFX.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
TFX vs PDEX Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, PDEX has a market cap of 213.6M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while PDEX trades at $66.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas PDEX's P/E ratio is 16.20. In terms of profitability, TFX's ROE is -0.32%, compared to PDEX's ROE of +0.31%. Regarding short-term risk, TFX is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for TFX.Check PDEX's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
TFX vs KRMD Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, KRMD has a market cap of 145.1M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while KRMD trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas KRMD's P/E ratio is -79.00. In terms of profitability, TFX's ROE is -0.32%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, TFX is more volatile compared to KRMD. This indicates higher risk in terms of short-term price fluctuations for TFX.Check KRMD's competition here
Stereotaxis, Inc. (AMEX: STXS)
TFX vs STXS Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, STXS has a market cap of 129.3M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while STXS trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas STXS's P/E ratio is -7.76. In terms of profitability, TFX's ROE is -0.32%, compared to STXS's ROE of -1.33%. Regarding short-term risk, TFX is more volatile compared to STXS. This indicates higher risk in terms of short-term price fluctuations for TFX.Check STXS's competition here
Daxor Corporation (NASDAQ: DXR)
TFX vs DXR Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, DXR has a market cap of 68M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while DXR trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas DXR's P/E ratio is 9.47. In terms of profitability, TFX's ROE is -0.32%, compared to DXR's ROE of +0.13%. Regarding short-term risk, TFX is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for TFX.Check DXR's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
TFX vs AKYA Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas AKYA's P/E ratio is -1.34. In terms of profitability, TFX's ROE is -0.32%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, TFX is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for TFX.Check AKYA's competition here
SkyAI, Inc. (NASDAQ: STSS)
TFX vs STSS Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas STSS's P/E ratio is -0.02. In terms of profitability, TFX's ROE is -0.32%, compared to STSS's ROE of -1.54%. Regarding short-term risk, TFX is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for TFX.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
TFX vs OMIC Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas OMIC's P/E ratio is -0.58. In terms of profitability, TFX's ROE is -0.32%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, TFX is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for TFX.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
TFX vs IGAP Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas IGAP's P/E ratio is -10.52. In terms of profitability, TFX's ROE is -0.32%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, TFX is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for TFX.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
TFX vs NEPH Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, NEPH has a market cap of 46.6M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while NEPH trades at $4.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas NEPH's P/E ratio is 71.50. In terms of profitability, TFX's ROE is -0.32%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, TFX is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for TFX.Check NEPH's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
TFX vs POCI Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, POCI has a market cap of 46.1M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while POCI trades at $4.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas POCI's P/E ratio is -6.68. In terms of profitability, TFX's ROE is -0.32%, compared to POCI's ROE of -0.37%. Regarding short-term risk, TFX is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for TFX.Check POCI's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
TFX vs HBIO Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, HBIO has a market cap of 36M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while HBIO trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas HBIO's P/E ratio is -22.17. In terms of profitability, TFX's ROE is -0.32%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, TFX is more volatile compared to HBIO. This indicates higher risk in terms of short-term price fluctuations for TFX.Check HBIO's competition here
Milestone Scientific Inc. (AMEX: MLSS)
TFX vs MLSS Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, MLSS has a market cap of 35.5M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while MLSS trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas MLSS's P/E ratio is -8.02. In terms of profitability, TFX's ROE is -0.32%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, TFX is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for TFX.Check MLSS's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
TFX vs SDC Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas SDC's P/E ratio is -0.03. In terms of profitability, TFX's ROE is -0.32%, compared to SDC's ROE of -1.96%. Regarding short-term risk, TFX is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for TFX.Check SDC's competition here
Invacare Corporation (NYSE: IVC)
TFX vs IVC Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas IVC's P/E ratio is -0.79. In terms of profitability, TFX's ROE is -0.32%, compared to IVC's ROE of -0.46%. Regarding short-term risk, TFX is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for TFX.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
TFX vs RVP Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, RVP has a market cap of 20.4M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while RVP trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas RVP's P/E ratio is -5.67. In terms of profitability, TFX's ROE is -0.32%, compared to RVP's ROE of -0.05%. Regarding short-term risk, TFX is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for TFX.Check RVP's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
TFX vs BNGO Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, BNGO has a market cap of 17.9M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while BNGO trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas BNGO's P/E ratio is -0.36. In terms of profitability, TFX's ROE is -0.32%, compared to BNGO's ROE of -0.79%. Regarding short-term risk, TFX is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for TFX.Check BNGO's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
TFX vs ZJYL Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, ZJYL has a market cap of 15.6M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while ZJYL trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas ZJYL's P/E ratio is 13.61. In terms of profitability, TFX's ROE is -0.32%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, TFX is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for TFX.Check ZJYL's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
TFX vs RGNT Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, RGNT has a market cap of 12.6M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while RGNT trades at $1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas RGNT's P/E ratio is -0.07. In terms of profitability, TFX's ROE is -0.32%, compared to RGNT's ROE of N/A. Regarding short-term risk, TFX is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for TFX.Check RGNT's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
TFX vs CUPR Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, CUPR has a market cap of 7.9M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while CUPR trades at $2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas CUPR's P/E ratio is -2.12. In terms of profitability, TFX's ROE is -0.32%, compared to CUPR's ROE of -15.69%. Regarding short-term risk, TFX is less volatile compared to CUPR. This indicates lower risk in terms of short-term price fluctuations for TFX.Check CUPR's competition here
Femasys Inc. (NASDAQ: FEMY)
TFX vs FEMY Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, FEMY has a market cap of 7.7M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while FEMY trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas FEMY's P/E ratio is -0.57. In terms of profitability, TFX's ROE is -0.32%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, TFX is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for TFX.Check FEMY's competition here
Lucyd, Inc (NASDAQ: LUCY)
TFX vs LUCY Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, LUCY has a market cap of 5.2M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while LUCY trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas LUCY's P/E ratio is -0.49. In terms of profitability, TFX's ROE is -0.32%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, TFX is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for TFX.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
TFX vs NSTG Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas NSTG's P/E ratio is -0.03. In terms of profitability, TFX's ROE is -0.32%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, TFX is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for TFX.Check NSTG's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
TFX vs POAI Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas POAI's P/E ratio is -0.03. In terms of profitability, TFX's ROE is -0.32%, compared to POAI's ROE of -21.19%. Regarding short-term risk, TFX is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for TFX.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
TFX vs MHUA Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas MHUA's P/E ratio is 0.25. In terms of profitability, TFX's ROE is -0.32%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, TFX is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for TFX.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
TFX vs NXGL Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, NXGL has a market cap of 2.4M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while NXGL trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas NXGL's P/E ratio is -0.40. In terms of profitability, TFX's ROE is -0.32%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, TFX is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for TFX.Check NXGL's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
TFX vs GMVD Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas GMVD's P/E ratio is -0.01. In terms of profitability, TFX's ROE is -0.32%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, TFX is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for TFX.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
TFX vs GMVDW Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas GMVDW's P/E ratio is N/A. In terms of profitability, TFX's ROE is -0.32%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, TFX is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for TFX.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
TFX vs AVGR Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas AVGR's P/E ratio is -0.05. In terms of profitability, TFX's ROE is -0.32%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, TFX is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for TFX.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
TFX vs NXGLW Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, NXGLW has a market cap of 1.2M. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while NXGLW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas NXGLW's P/E ratio is -0.02. In terms of profitability, TFX's ROE is -0.32%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, TFX is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for TFX.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
TFX vs LUCYW Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas LUCYW's P/E ratio is N/A. In terms of profitability, TFX's ROE is -0.32%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, TFX is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for TFX.Check LUCYW's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
TFX vs ATRS Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas ATRS's P/E ratio is 14.95. In terms of profitability, TFX's ROE is -0.32%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, TFX is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for TFX.Check ATRS's competition here
Apria, Inc. (NASDAQ: APR)
TFX vs APR Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, APR has a market cap of 0. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas APR's P/E ratio is 22.59. In terms of profitability, TFX's ROE is -0.32%, compared to APR's ROE of +9.81%. Regarding short-term risk, TFX is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for TFX.Check APR's competition here
IntriCon Corporation (NASDAQ: IIN)
TFX vs IIN Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, IIN has a market cap of 0. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas IIN's P/E ratio is 226.45. In terms of profitability, TFX's ROE is -0.32%, compared to IIN's ROE of -0.00%. Regarding short-term risk, TFX is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for TFX.Check IIN's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
TFX vs HRC Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, HRC has a market cap of 0. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas HRC's P/E ratio is 41.92. In terms of profitability, TFX's ROE is -0.32%, compared to HRC's ROE of +0.14%. Regarding short-term risk, TFX is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for TFX.Check HRC's competition here
Analogic Corporation (NASDAQ: ALOG)
TFX vs ALOG Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas ALOG's P/E ratio is 40.93. In terms of profitability, TFX's ROE is -0.32%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, TFX is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for TFX.Check ALOG's competition here
Invuity, Inc. (NASDAQ: IVTY)
TFX vs IVTY Comparison September 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 5.7B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, TFX is priced at $129.02 on the NYSE, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 14.75, whereas IVTY's P/E ratio is -3.80. In terms of profitability, TFX's ROE is -0.32%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, TFX is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for TFX.Check IVTY's competition here